About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Contact the Docs

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc. (Fed. Cir. 2024) | Main | United Therapeutics Corp. v. Liquidia Technologies Inc. (Fed. Cir. 2024) »

August 12, 2024

Comments

Are we surprised?

Excellent article - I very much appreciate the independent research.
One quick note: the term "examiner allowance rates" was confusing, and it took a re-read to confirm that was supposed to be "examiner affirmance rates."

Michael,

Yes, thanks, we caught that typo early this morning and fixed it recently. Sorry for any confusion.

Mike

What could be causing the disparity between 101 rejections and other types of rejections? One possibility: examiners are generally making 101 rejections consistent with the USPTO guidance, and it's primarily hopeless cases from obstinate appellants that are getting sent to the PTAB. Another possibility: examiners are maintaining rejections only of the most egregiously ineligible inventions, and letting pass a lot of applications that are still ineligible, but less blatantly so.

Putting aside the shortcomings of the Alice/Mayo test, isn't the high affirmance rate a sign that the test is being applied in a consistent way (i.e. the opposite of a hot mess)?

Kyle,

The test is applied very inconsistently between TCs (as shown) and also from examiner to examiner. But the PTAB will consistently affirm 101 rejections. From the viewpoint of a new invention, the actual risk of 101 issues is effectively an unknown. We employ a number of techniques to draft applications such that the likelihood of a tough TC is low and such that the application has built-in 101 rebuttals. But doing so will not work for all examiners. All inventions involving software (and many that do not) are at risk.

Mike

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.

Your Information

(Name is required. Email address will not be displayed with the comment.)

September 2024

Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30